University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Treatment of Chronic Antibody-mediated Rejection in Kidney Transplant With Acthar

Phase 4

Terminated

Conditions: Transplant Glomerulopathy

Interventions: Drug: Acthar gel

First Posted Date: 2015-09-11

Last Posted Date: 2022-10-06

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 6

Registration Number: NCT02546492

Locations: 🇺🇸
Unniversity of Maryland Medical Center, Baltimore, Maryland, United States
🇺🇸
University of Alabama School of Medicine, Alabama Transplant Center, Birmingham, Alabama, United States

Enhance Balance and Mobility in People With Type 2 Diabetic Peripheral Neuropathy

Not Applicable

Terminated

Conditions: Diabetes Complications
Diabetic Neuropathies

Interventions: Other: Muscle power
Other: balance perturbation
Other: aerobic exercise

First Posted Date: 2015-09-04

Last Posted Date: 2022-01-31

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 3

Registration Number: NCT02541838

Locations: 🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States
🇺🇸
VA Maryland Health Care System, Baltimore, Maryland, United States

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

Phase 2

Withdrawn

Conditions: Prostate Cancer
Non-Small Cell Lung Cancer
Breast Cancer

Interventions: Drug: RQ-00000007
Drug: Gemcitabine

First Posted Date: 2015-09-02

Last Posted Date: 2019-11-04

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT02538432

Fentanyl Patch Pharmacokinetics in Healthy Adults

Phase 4

Completed

Conditions: Peer Review, Research

Interventions: Drug: Intravenous fentanyl citrate
Drug: Duragesic®
Drug: Mylan generic fentanyl

First Posted Date: 2015-08-25

Last Posted Date: 2020-03-26

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 24

Registration Number: NCT02531971

Locations: 🇺🇸
General Clinical Research Center, Baltimore, Maryland, United States

Skin Prep to Reduce Postoperative Shoulder Infection

Not Applicable

Completed

Conditions: Shoulder Infection

Interventions: Drug: Skin Prep Chlorhexidine
Drug: Skin Prep Benzoyl Peroxide

First Posted Date: 2015-07-29

Last Posted Date: 2020-02-11

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 80

Registration Number: NCT02510144

Locations: 🇺🇸
University of Maryland Midtown Hospital, Baltimore, Maryland, United States

Assessing The Effects of Exercise, Protein, and Electric Stimulation On Intensive Care Unit Patients Outcomes

Not Applicable

Active, not recruiting

Conditions: Critical Illness
Muscle Weakness
Sarcopenia

Interventions: Dietary Supplement: MPR and High Protein Supplement (HPRO) and Neuromuscular Electric Stimulation (NMES)

First Posted Date: 2015-07-28

Last Posted Date: 2024-02-13

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 60

Registration Number: NCT02509520

Locations: 🇺🇸
U of Maryland, Baltimore, Professional Schools IRB, Baltimore, Maryland, United States

Study of Airway Pressure Release Ventilation and Intracranial Pressure in Patients With Severe Traumatic Brain Injury

Terminated

Conditions: Traumatic Brain Injury
Injury, Brain, Traumatic

Interventions: Other: Low Tidal Volume Ventilation
Other: Airway Pressure Release Ventilation

First Posted Date: 2015-07-24

Last Posted Date: 2022-01-28

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 8

Registration Number: NCT02507973

Locations: 🇺🇸
RA Cowley Shock Trauma Center, Baltimore, Maryland, United States

The Gamma Pod: A Clinical Feasibility Study Device GCC 1202: The Gamma Pod: A Clinical Feasibility Study

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Device: The Gamma Pod
Device: CT simulation

First Posted Date: 2015-07-24

Last Posted Date: 2022-01-14

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 17

Registration Number: NCT02507960

Locations: 🇺🇸
Ummc Msgccc, Baltimore, Maryland, United States
🇺🇸
Upper Chesapeake Health, Bel Air, Maryland, United States
🇺🇸
Central Maryland Oncology Center, Columbia, Maryland, United States

and more 1 locations

Transdermal Patch CVD 2000: The Effect of Heat on Fentanyl Release From Fentanyl TDSs in Healthy Adults

Phase 4

Completed

Conditions: Peer Review, Research

Interventions: Drug: Apotex generic fentanyl TDS
Drug: Duragesic reference fentanyl TDS
Drug: Mylan generic fentanyl TDS

First Posted Date: 2015-06-30

Last Posted Date: 2020-03-23

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 10

Registration Number: NCT02486016

Locations: 🇺🇸
University of Maryland, Baltimore Center for Vaccine Development, Baltimore, Maryland, United States

Pharmacogenetics of SGLT2 Inhibitors

Phase 4

Terminated

Conditions: Diabetes Mellitus
Gout
Hyperuricemia

Interventions: Drug: Canagliflozin

First Posted Date: 2015-06-04

Last Posted Date: 2022-08-02

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 30

Registration Number: NCT02462421

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy